mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous Carcinomas

Abstract

The emerging results may provide a rationale for the clinical evaluation of mTOR inhibitors as a molecular targeted approach for the treatment of HPV-associated malignancies.